Moving beyond the traditional two-step approach for prognosis prediction: The BayeSarc model.Gabriele Tinè, Rosalba Miceli, Peter C. Ferguson et al.|Journal of Clinical Oncology|2025Cited by 2
Abstract CT054: The development of a personalized autologous clonal neoantigen T cell therapy for the treatment of solid cancer using the VELOSTM manufacturing platform generates highly potent and reactive CD8+ and CD4+ T cells for clinical useHenrieta Fraser, Edward Samuel, Rebecca Pike et al.|Cancer Research|2020Cited by 0